Biopharm Company News - BioPharm International


Biopharm Company News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

Merck Cuts 8,500 Positions, Moves Headquarters

October 1, 2013

Merck announced plans to reduce its workforce by 8,500 and move its headquarters in order to sharpen its commercial and R&D focus.

Merck & Co. Receives Complete Response Letter From FDA Regarding Sugammadex Sodium Injection

September 27, 2013

Merck & Co. has received a Complete Response Letter from FDA for the resubmission of its new drug application for sugammadex sodium injection.

J&J's Janssen and PATH Partner to Develop Rilpivirine Formulation

September 27, 2013

J&J's Janssen and PATH partner to improve drug formulation that could help prevent HIV infection.

Cell Medica Opens Commercial Manufacturing Facility

September 26, 2013

Cell Medica, a T cell therapeutics company, has opened a European manufacturing facility in Berlin-Buch, Germany to develop, manufacture, and market treatments of infections and cancers related to oncogenic viruses.

JHL Biotech to Build KUBio Modular Facility

September 25, 2013

GE Healthcare Life Sciences announced that it will build a KUBio modular biopharmaceutical factory in China for JHL Biotech.

AstraZeneca, Bristol-Myers Squibb Recall Certain Lots of Bydureon

September 24, 2013

AstraZeneca, Bristol-Myers Squibb recall certain lots of of their antidiabetes drug Bydureon (eventide) due to manufacturing records that batches may contain underfilled vials.

Unilife Signs Supply Contract with Sanofi for Prefilled Syringes

September 18, 2013

Unilife grants Sanofi long-term exclusivity for the use of Unilife?s prefilled syringe with Sanofi?s Lovenox.

Myriad Genetics Expands Companion Diagnostic Pact with AstraZeneca

September 9, 2013

Myriad Genetics and AstraZeneca expand their companion diagnostic pact for AztraZeneca?s investigational drug candidate olaparib.

CordenPharma to Acquire Peptisyntha SA from Solvay

September 5, 2013

CordenPharma will acquire Peptisyntha SA, based in Belgium.



Click here